Bio-Techne to Present at Upcoming Investor Conferences
Bio-Techne (NASDAQ: TECH) will present at three investor conferences in early December 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) will present at three investor conferences in early December 2025.
Events and times:
- Evercore Healthcare Conference — December 2, 2025 at 8:20 AM ET
- Citi Global Healthcare Conference — December 3, 2025 at 3:15 PM ET
- Nasdaq Investor Conference — December 9, 2025 at 9:30 AM GMT
A live webcast of each presentation will be available via Bio-Techne's investor relations IR Calendar page: https://investors.bio-techne.com/ir-calendar.
Details
News Market Reaction – TECH
On Nov 25, the day this news came out, TECH closed 3.72% above the previous close.
Data tracked by StockTitan Argus for the Nov 25 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
8th Annual Evercore Healthcare Conference 2025
December 2, 2025
8:20 AM EST
Citi's 2025 Global Healthcare Conference
December 3, 2025
3:15 PM EST
53rd Annual Nasdaq Investor Conference
December 9, 2025
9:30 AM GMT
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over
Contact: David Clair, Vice President, Investor Relations & Corporate Development
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302625027.html
SOURCE Bio-Techne Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
